Xilio Therapeutics Inc. (XLO) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Xilio Therapeutics Inc.

    NASDAQ: XLO · Real-Time Price · USD
    0.69
    -0.00 (-0.07%)
    At close: Aug 29, 2025, 11:42 AM

    Xilio Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -0.88 -0.2 -0.84 -5.89
    PEG Ratio
    		 0.01 0.02 -0.05 -0.17
    PS Ratio
    		 8.06 n/a n/a n/a
    PB Ratio
    		 2.90 0.41 0.70 2.36
    P/FCF Ratio
    		 -2.78 -218.83 -0.95 -5.35
    P/OCF Ratio
    		 -2.78 -0.22 -0.97 -5.42
    OCF/S Ratio
    		 -2.9 n/a n/a n/a
    Debt / Equity Ratio
    		 0.46 0.31 0.19 0.11
    Quick Ratio
    		 2.21 3.02 5.89 15.85
    Current Ratio
    		 2.21 3.02 5.89 15.85
    Asset Turnover
    		 0.09 n/a n/a n/a
    Interest Coverage
    		 -605.82 n/a n/a -125.07
    Return on Equity
    		 -3.31 -2.07 -0.83 -0.4
    Return on Assets
    		 -0.82 -1.25 -0.63 -0.34
    Return on Invested Capital
    		 -1.35 -1.64 -0.7 -0.36
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 1.00 n/a n/a n/a
    Net Profit Margin
    		 -9.18 n/a n/a n/a
    Pretax Profit Margin
    		 -9.18 n/a n/a n/a
    Operating Profit Margin
    		 -9.55 n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 -9.14 n/a n/a n/a

    Add to Watchlist